Peripherally inserted central catheter-related vein thrombosis in breast cancer patients

Journal of Vascular Access

Volumn 17, Issue 1, 2016, Pages 67-71

  Kang, Junren ^a   Sun, Wenyan ^a   Li, Hailong ^a   Ma, Enling ^a   Wang, Kai ^a   Chen, Wei ^a  

^a PEKING UNION MEDICAL COLLEGE HOSPITAL   (China)

Author keywords

Breast cancer; Chemotherapy; Peripherally inserted central venous catheter; Upper extremity deep vein thrombosis

Indexed keywords

CYCLOPHOSPHAMIDE; DOCETAXEL; DOXORUBICIN; LOW MOLECULAR WEIGHT HEPARIN; ANTINEOPLASTIC AGENT;

ADULT; ARTICLE; BREAST CANCER; BREAST CARCINOMA; CENTRAL VENOUS CATHETER; DEVICE POSITION; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MEDICAL PARAMETERS; METASTASIS; MIDDLE AGED; PAIN; RETROSPECTIVE STUDY; SWELLING; UPPER EXTREMITY DEEP VEIN THROMBOSIS; ADVERSE EFFECTS; BREAST NEOPLASMS; CATHETERIZATION; CENTRAL VENOUS CATHETERIZATION; CHINA; DIAGNOSTIC IMAGING; INCIDENCE; MULTIVARIATE ANALYSIS; ODDS RATIO; PATHOLOGY; RISK FACTOR; STATISTICAL MODEL; TIME FACTOR; TREATMENT OUTCOME;

ADULT; ANTINEOPLASTIC AGENTS; BREAST NEOPLASMS; CATHETERIZATION, CENTRAL VENOUS; CATHETERIZATION, PERIPHERAL; CHINA; FEMALE; HUMANS; INCIDENCE; LOGISTIC MODELS; MIDDLE AGED; MULTIVARIATE ANALYSIS; NEOPLASM METASTASIS; ODDS RATIO; RETROSPECTIVE STUDIES; RISK FACTORS; TIME FACTORS; TREATMENT OUTCOME; UPPER EXTREMITY DEEP VEIN THROMBOSIS;

EID: 84956937489     PISSN: 11297298     EISSN: 17246032     Source Type: Journal    
DOI: 10.5301/jva.5000457     Document Type: Article

References (31)

1. Chopra V, Ratz D, Kuhn L, Lopus T, Lee A, Krein S. Peripherally inserted central catheter-related deep vein thrombosis: contemporary patterns and predictors. J Thromb Haemost. 2014; 12(6):847-854.
2. Evans RS, Sharp JH, Linford LH, et al. Reduction of peripherally inserted central catheter-associated DVT. Chest. 2013;143(3): 627-633.
3. Coady K, Ali M, Sidloff D, Kenningham RR, Ahmed S. A comparison of infections and complications in central venous catheters in adults with solid tumours. J Vasc Access. 2015;16(1):38-41.
4. Chopra V, Anand S, Hickner A, et al. Risk of venous thromboembolism associated with peripherally inserted central catheters: a systematic review and meta-analysis. Lancet. 2013;382(9889): 311-325.
5. Evans RS, Sharp JH, Linford LH, et al. Risk of symptomatic DVT associated with peripherally inserted central catheters. Chest. 2010;138(4):803-810.
6. Aw A, Carrier M, Koczerginski J, McDiarmid S, Tay J. Incidence and predictive factors of symptomatic thrombosis related to peripherally inserted central catheters in chemotherapy patients. Thromb Res. 2012;130(3):323-326.
7. Wilson TJ, Brown DL, Meurer WJ, Stetler WR Jr, Wilkinson DA, Fletcher JJ. Risk factors associated with peripherally inserted central venous catheter-related large vein thrombosis in neurological intensive care patients. Intensive Care Med. 2012; 38(2):272-278.
8. Tran H, Arellano M, Chamsuddin A, et al. Deep venous thromboses in patients with hematological malignancies after peripherally inserted central venous catheters. Leuk Lymphoma. 2010;51(8):1473-1477.
9. Bonizzoli M, Batacchi S, Cianchi G, et al. Peripherally inserted central venous catheters and central venous catheters related thrombosis in post-critical patients. Intensive Care Med. 2011;37(2):284-289.
10. Zochios V, Umar I, Simpson N, Jones N. Peripherally inserted central catheter (PICC)-related thrombosis in critically ill patients. J Vasc Access. 2014;15(5):329-337.
11. Marnejon T, Angelo D, Abu Abdou A, Gemmel D. Risk factors for upper extremity venous thrombosis associated with peripherally inserted central venous catheters. J Vasc Access. 2012;13(2):231-238.
12. Tran BH, Nguyen TJ, Hwang BH, et al. Risk factors associated with venous thromboembolism in 49,028 mastectomy patients. Breast. 2013;22(4):444-448.
13. Sperry BW, Roskos M, Oskoui R. The effect of laterality on venous thromboembolism formation after peripherally inserted central catheter placement. J Vasc Access. 2012;13(1):91-95.
14. Petterson TM, Marks RS, Ashrani AA, Bailey KR, Heit JA. Risk of site-specific cancer in incident venous thromboembolism: a population-based study. Thromb Res. 2015;135(3): 472-478.
15. Yap YS, Karapetis C, Lerose S, Iyer S, Koczwara B. Reducing the risk of peripherally inserted central catheter line complications in the oncology setting. Eur J Cancer Care (Engl). 2006;15(4): 342-347.
16. Lee AY, Kamphuisen PW. Epidemiology and prevention of catheter-related thrombosis in patients with cancer. J Thromb Haemost. 2012;10(8):1491-1499.
17. Saber W, Moua T, Williams EC, et al. Risk factors for catheterrelated thrombosis (CRT) in cancer patients: a patient-level data (IPD) meta-analysis of clinical trials and prospective studies. J Thromb Haemost. 2011;9(2):312-319.
18. Verso M, Agnelli G, Kamphuisen PW, et al. Risk factors for upper limb deep vein thrombosis associated with the use of central vein catheter in cancer patients. Intern Emerg Med. 2008; 3(2):117-122.
19. Verso M, Gussoni G, Agnelli G. Prevention of venous thromboembolism in patients with advanced lung cancer receiving chemotherapy: a combined analysis of the PROTECHT and TOPIC-2 studies. J Thromb Haemost. 2010;8(7):1649-1651.
20. Amerasekera SS, Jones CM, Patel R, Cleasby MJ. Imaging of the complications of peripherally inserted central venous catheters. Clin Radiol. 2009;64(8):832-840.
21. Lobo BL, Vaidean G, Broyles J, Reaves AB, Shorr RI. Risk of venous thromboembolism in hospitalized patients with peripherally inserted central catheters. J Hosp Med. 2009;4(7): 417-422.
22. Liem TK, Yanit KE, Moseley SE, et al. Peripherally inserted central catheter usage patterns and associated symptomatic upper extremity venous thrombosis. J Vasc Surg. 2012;55(3): 761-767.
23. Piran S, Ngo V, McDiarmid S, Le Gal G, Petrcich W, Carrier M. Incidence and risk factors of symptomatic venous thromboembolism related to implanted ports in cancer patients. Thromb Res. 2014;133(1):30-33.
24. Lin J, Wakefield TW, Henke PK. Risk factors associated with venous thromboembolic events in patients with malignancy. Blood Coagul Fibrinolysis. 2006;17(4):265-270.
25. Tesselaar ME, Ouwerkerk J, Nooy MA, Rosendaal FR, Osanto S. Risk factors for catheter-related thrombosis in cancer patients. Eur J Cancer. 2004;40(15):2253-2259.
26. Baarslag HJ, van Beek EJ, Koopman MM, Reekers JA. Prospective study of color duplex ultrasonography compared with contrast venography in patients suspected of having deep venous thrombosis of the upper extremities. Ann Intern Med. 2002;136(12):865-872.
27. Guyatt GH, Akl EA, Crowther M, et al. Executive summary: antithrombotic therapy and prevention of thrombosis, 9th ed: American College of Chest Physicians evidence-based clinical practice guidelines. Chest. 2012;142(2 Suppl):7S-47S.
28. Kovacs MJ, Kahn SR, Rodger M, et al. A pilot study of central venous catheter survival in cancer patients using low-molecular- weight heparin (dalteparin) and warfarin without catheter removal for the treatment of upper extremity deep vein thrombosis (The Catheter Study). J Thromb Haemost. 2007;5(8): 1650-1653.
29. Faustino EV, Spinella PC, Li S, et al. Incidence and acute complications of asymptomatic central venous catheter-related deep venous thrombosis in critically ill children. J Pediatr. 2013;162(2):387-391.
30. Debourdeau P, Farge D, Beckers M, et al. International clinical practice guidelines for the treatment and prophylaxis of thrombosis associated with central venous catheters in patients with cancer. J Thromb Haemost. 2013;11(1):71-80.
31. Masoomi H, Paydar KZ, Wirth GA, Aly A, Kobayashi MR, Evans GR. Predictive risk factors of venous thromboembolism in autologous breast reconstruction surgery. Ann Plast Surg. 2014; 72(1):30-33.